These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22127509)

  • 1. Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome.
    Raymond VM; Herron CM; Giordano TJ; Gruber SB
    Fam Cancer; 2012 Mar; 11(1):115-21. PubMed ID: 22127509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
    Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
    Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of hereditary leiomyomatosis renal cell carcinoma with focus on clinical and pathobiological aspects of renal tumors.
    Kuroda N; Ohe C; Kato I; Furuya M; Baba M; Nagashima Y; Nakatani Y; Murakami I; Zhou M; Michal M; He O; Amin MB
    Pol J Pathol; 2017; 68(4):284-290. PubMed ID: 29517197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
    Plevová P; Hladíková A; Tesařová M
    Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance.
    van Spaendonck-Zwarts KY; Badeloe S; Oosting SF; Hovenga S; Semmelink HJ; van Moorselaar RJ; van Waesberghe JH; Mensenkamp AR; Menko FH
    Fam Cancer; 2012 Mar; 11(1):123-9. PubMed ID: 22086304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.
    Choi G; Kimonis V; Hall K; Lau WL
    Am J Med Sci; 2020 Dec; 360(6):724-727. PubMed ID: 32703534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.
    Chen YB; Brannon AR; Toubaji A; Dudas ME; Won HH; Al-Ahmadie HA; Fine SW; Gopalan A; Frizzell N; Voss MH; Russo P; Berger MF; Tickoo SK; Reuter VE
    Am J Surg Pathol; 2014 May; 38(5):627-37. PubMed ID: 24441663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous leiomyosarcoma in a case of hereditary leiomyomatosis and renal cell carcinoma syndrome.
    O'Connor M; Paul M; Wylie G
    BMJ Case Rep; 2024 Aug; 17(8):. PubMed ID: 39179269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening.
    Garg K; Rabban J
    Genes Chromosomes Cancer; 2021 Mar; 60(3):210-216. PubMed ID: 33099845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review.
    Feng D; Wang M; Zhang X; Wang J
    Aktuelle Urol; 2021 Feb; 52(1):58-63. PubMed ID: 32932527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
    Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ
    J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
    Varol A; Stapleton K; Roscioli T
    Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas.
    Kuwada M; Chihara Y; Lou Y; Torimoto K; Kagebayashi Y; Tamura K; Shuin T; Fujimoto K; Kuniyasu H; Samma S
    BMC Res Notes; 2014 Mar; 7():203. PubMed ID: 24684806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
    Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
    Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.
    El-Zaatari Z; Divatia MK
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S7-S17. PubMed ID: 32108620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous leiomyomas: a clinical marker of risk for hereditary leiomyomatosis and renal cell cancer.
    Stewart L; Glenn G; Toro JR
    Dermatol Nurs; 2006 Aug; 18(4):335-41; quiz 342. PubMed ID: 16948378
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Leiomyomatosis and Renal Cell Cancer: A Rare Case in a 22-Year-Old Female.
    Guo F; Wang H
    Urology; 2023 May; 175():e1-e3. PubMed ID: 36764488
    [No Abstract]   [Full Text] [Related]  

  • 19. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
    Teh J; Kinnear N; Douglass-Molloy H; Hennessey DB
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28122802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
    Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.